Accessibility Menu
Morphic logo

Morphic(NASDAQ) MORF

This security has been delisted. This page is retained for historical reference.

Morphic last closing stock price
MetricPriceDate
Last closeUSD 56.992024-08-15
Morphic stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.19%USD 56.882024-08-08
1 month+1.79%USD 55.992024-07-16
3 month+94.97%USD 29.232024-05-17
Year to date+97.33%USD 28.882023-12-29
1 year+10.66%USD 51.502023-08-16
3 year-1.38%USD 57.792021-08-16
5 year+167.06%USD 21.342019-08-16
Since inception+216.61%USD 18.002019-06-27

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

MORF Financials

Key Financial Metrics (TTM)

Gross Margin

-109.40%

Operating Margin

-34296.74%

Net Income Margin

-29192.90%

Return on Equity

-29.08%

Return on Capital

-25.55%

Return on Assets

-21.05%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$61.36M

Operating Income

-$213.02M

EBITDA

-$211.89M

Operating Cash Flow

-$136.30M

Capital Expenditure

-$1.35M

Free Cash Flow

-$137.65M

Cash & ST Invst.

$628.37M

Total Debt

$3.32M

Morphic Performance Analysis

Morphic annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 19,794,000N/A
20222022-12-31USD 70,808,000257.7%
20232023-12-31USD 521,000-99.3%
Morphic sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30N/A
Q42023-12-31N/A
Q12024-03-31100.0%
Q22024-06-30N/A
Morphic annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -2.67N/A
20222022-12-31USD -1.55-42.0%
20232023-12-31USD -3.59131.6%
Morphic sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-3020.7%
Q42023-12-31-12.3%
Q12024-03-31-11.0%
Q22024-06-30-26.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$275.00K

-2.6%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

128

N/A

Net Income

-$57.59M

-47.6%

EBITDA

-$64.96M

-44.2%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$628.37M

-14.1%

Total Debt

$3.32M

+6.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.31M

-25.5%

Short Term Debt

$2.16M

+38.6%

Return on Assets

-21.05%

N/A

Return on Invested Capital

-25.61%

N/A

Free Cash Flow

-$32.36M

-38.7%

Operating Cash Flow

-$32.09M

-39.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MORMorphoSys AG
$18.96+2.43%
KDNYChinook Therapeutics, Inc.
$40.39+0.22%
MYOVMyovant Sciences Ltd.
$26.98-0.04%
DICEDICE Therapeutics, Inc.
$47.55+0.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
AALAmerican Airlines Group
$13.56-0.08%
INTCIntel
$100.23-0.02%
TSLATesla
$319.69-0.15%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.